HealthExec November 29, 2022
Boston Scientific Corporation, a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, has agreed to acquire Apollo Endosurgery in a $615 million deal.
Apollo Endosurgery is known for manufacturing medical devices used during endoluminal surgery (ELS) procedures to close gastrointestinal defects, manage gastrointestinal complications and aid in weight loss for patients suffering from obesity. The surgery type is less invasive compared to open and laparoscopic surgery for patients with gastrointestinal diseases or morbid obesity. ELS also has the potential for quicker recovery and fewer complications.
Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share, according to Market Watch. Upon news of...
Today's Sponsors
Today's Sponsor